Arcutis Biotherapeutics Inc (ARQT)
9.43
+0.17
(+1.84%)
USD |
NASDAQ |
Nov 18, 16:00
9.45
+0.02
(+0.21%)
After-Hours: 20:00
Arcutis Biotherapeutics Market Cap: 1.104B for Nov. 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2024 | 1.104B |
| November 15, 2024 | 1.084B |
| November 14, 2024 | 1.162B |
| November 13, 2024 | 1.225B |
| November 12, 2024 | 1.200B |
| November 11, 2024 | 1.269B |
| November 08, 2024 | 1.266B |
| November 07, 2024 | 1.217B |
| November 06, 2024 | 1.131B |
| November 05, 2024 | 1.089B |
| November 04, 2024 | 1.021B |
| November 01, 2024 | 1.015B |
| October 31, 2024 | 972.26M |
| October 30, 2024 | 996.83M |
| October 29, 2024 | 1.002B |
| October 28, 2024 | 1.019B |
| October 25, 2024 | 1.024B |
| October 24, 2024 | 983.96M |
| October 23, 2024 | 976.94M |
| October 22, 2024 | 975.77M |
| October 21, 2024 | 972.26M |
| October 18, 2024 | 1.020B |
| October 17, 2024 | 1.110B |
| October 16, 2024 | 1.137B |
| October 15, 2024 | 1.094B |
| Date | Value |
|---|---|
| October 14, 2024 | 1.140B |
| October 11, 2024 | 1.145B |
| October 10, 2024 | 1.144B |
| October 09, 2024 | 1.147B |
| October 08, 2024 | 1.133B |
| October 07, 2024 | 1.145B |
| October 04, 2024 | 1.172B |
| October 03, 2024 | 1.190B |
| October 02, 2024 | 1.197B |
| October 01, 2024 | 1.117B |
| September 30, 2024 | 1.088B |
| September 27, 2024 | 1.094B |
| September 26, 2024 | 1.071B |
| September 25, 2024 | 1.064B |
| September 24, 2024 | 1.132B |
| September 23, 2024 | 1.126B |
| September 20, 2024 | 1.186B |
| September 19, 2024 | 1.185B |
| September 18, 2024 | 1.216B |
| September 17, 2024 | 1.212B |
| September 16, 2024 | 1.188B |
| September 13, 2024 | 1.246B |
| September 12, 2024 | 1.230B |
| September 11, 2024 | 1.230B |
| September 10, 2024 | 1.271B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
149.39M
Minimum
Oct 23 2023
1.837B
Maximum
Feb 08 2021
992.09M
Average
1.038B
Median
Apr 29 2022
Market Cap Benchmarks
| Mirum Pharmaceuticals Inc | 1.988B |
| Biogen Inc | 23.01B |
| Vertex Pharmaceuticals Inc | 120.27B |
| NovaBay Pharmaceuticals Inc | 3.419M |
| Palatin Technologies Inc | 18.57M |
Market Cap Related Metrics
| PS Ratio | 7.744 |
| Price to Book Value | 7.046 |
| Price | 9.43 |
| Earnings Yield | -18.98% |